169158 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
Low affinity FCGR deficient mice
#602TUMOUR CELL AND TISSUE CULTURE
#603Humanized Fc gamma R mice
#604Vitro method for high throughput screening of genotoxic agents in eukaryotic cells
#605Method of determining, identifying or isolating cell-penetrating peptides
#606Hanging droplet plate
#607Medical device design, manufacture and testing systems
#608KIT FOR DRUG METABOLISM DETERMINATION AND TOXICITY PREDICTION
#609Culture medium composition and method of culturing cell or tissue using thereof
#610PHOTOTOXICITY TEST METHOD
#611TDP-43-storing cell model
#612Cells useful for immuno-based botulinum toxin serotype a activity assays
#613In vitro method for determining immunotoxicity of a compound
#614T-CELL DEATH-INDUCING EPITOPES
#615ADJUVANTS THAT ACTIVATE ADAPTIVE IMMUNE SYSTEM BY STIMULATING NLRP3
#616Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
#617Method for the determination of botulinum neurotoxin biological activity
#618Kits and methods for cyanide detection
#619CD16A REPORTER ASSAY FOR EVALUATION OF ADCC POTENTIAL OF BIOLOGICS
#620Cell transplantation
#621Kits for detecting and monitoring endocrine disrupting chemicals (EDCs)
#622Genotoxicity as a biomarker for inflammation
#623Methods of screening agents for activity using teleosts
#624DEVICE FOR ANALYZING THE EFFECTS OF AT LEAST ONE PARAMETER RELATING TO A VOLATILE SUBSTANCE
#625Method for manufacturing an analysis substrate, and use thereof for detecting toxins
#626Methods of screening chemotherapeutic agents and treating cancer
#627Polyethylene glycolated superoxide dismutase mimetics
#628Sensitive high throughput method for DNA damage and repair
#629Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#630Device for analyzing the effect of a gaseous medium on a biological test system using an extracellular metabolization system
#631Cell-based antioxidant protection assay
#632TOXICITY SCREENING METHODS
#633Modulators of alpha-synuclein toxicity
#634Method of deriving mature hepatocytes from human embryonic stem cells
#635COMPOSITIONS AND ASSAYS FOR DETERMINING CELL VIABILITY
#636Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
#637Real-time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
#638METHODS AND COMPOSITIONS FOR THE STABILIZATION OF BIOLOGIC MATERIAL
#639Sperm-specific cation channel, CatSper4, and uses therefor
#640Method of toxicological evaluation, method of toxicological screening and associated system
#641Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof
#642Panels of immortalized mammalian cells and their use
#643METHODS AND KITS FOR DETERMINING THE TOXICITY OF AN AGENT
#644IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#645Method for determining genotoxicity using non-fluorescent proteins
#646Methods of treating and preventing infections and associated conditions
#647Methods for screening antibodies
#648Pharmacologic method of lowering cholesterol production
#649Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways
#650METHODS OF SCREENING AGENTS FOR ACTIVITY USING TELEOSTS
#651Toxicology and cellular effect of manufactured nanomaterials
#6523D ADCC NK FACS ASSAY
#653Transgenic biosensors
#654In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes
#655POLYETHYLENE GLYCOLATED SUPEROXIDE DISMUTASE MIMETICS
#656Dynamic monitoring of activation of receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
#657Methods of measuring cell viability in tissue engineered products
#658Low affinity FcγR deficient mice
#659METHODS OF DETECTING DNA DAMAGE
#660PEPTIDE MARKER FOR CANCER DIAGNOSIS, AND CANCER DIAGNOSIS METHOD USING SAME
#661Methods for Screening for Agents that Affect Development
#662HUMAN EMBRYONIC STEM CELLS FOR HIGH THROUGHOUT DRUG SCREENING
#663TRACEABLE RETINOID ACID FOR IMAGING, DISEASE PREVENTION AND THERAPY
#664Methods for identifying inhibitors of botulinum neurotoxins
#665Lipophilic dye-based FRET assays for clostridial toxin activity
#666Immuno-based botulinum toxin serotype A activity assays
#667Toxicity typing using liver stem cells
#668Method for the toxicity assessments of nano-materials
#669Predicting toxicity of a compound over a range of concentrations
#670Cells useful for immuno-based botulinum toxin serotype A activity assays
#671Cells useful for immuno-based botulinum toxin serotype A activity assays
#672Cells useful for immuno-based botulinum toxin serotype A activity assays
#673Cells useful for immuno-based botulinum toxin serotype A activity assays
#674Method and assembly for determining cell vitalities
#675TOXICITY SCREENING METHODS
#676Cells useful for immuno-based botulinum toxin serotype A activity assays
#677Cells useful for immuno-based botulinum toxin serotype A activity assays
#678Cells useful for immuno-based botulinum toxin serotype A activity assays
#679Cells useful for immuno-based botulinum toxin serotype A activity assays
#680Cells useful for immuno-based Botulinum toxin serotype A activity assays
#681Environmental Sentinel Biomonitor System (ESB)
#682Cells useful for immuno-based botulinum toxin serotype A activity assays
#683Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#684Cells useful for immuno-based botulinum toxin serotype A activity assays
#685Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#686Method of determining cell number or viability using hydroxyethyldisulfide
#687Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof
#688Method and Apparatus for Evaluation of Toxicity
#689Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform
#690Rapid in vivo gene mutation assay based on the Pig-A gene
#691Immuno-based botulinum toxin serotype A activity assays
#692Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#693Methods for assessing and identifying or evolving conditionally active therapeutic proteins
#694METHODS FOR PREDICTING THE TOXICITY OF A CHEMICAL
#695METHODS FOR DETERMINING EFFICACY OF CHEMOTHERAPEUTIC AGENTS
#696CYANINE COMPOUNDS, CONJUGATES AND METHOD OF USE
#697METHOD FOR SCREENING COMPOUNDS FOR THE TREATMENT OR PREVENTION OF COLON CANCER
#698Stabilized bioactive peptides and methods of identification, synthesis, and use
#699PORTABLE DEVICE BASED ON IMMOBILIZED CELLS FOR THE DETECTION OF ANALYTES
#700GENOTOXICITY TESTING
#701METHOD FOR OBTAINING A SINGULAR CELL MODEL CAPABLE OF REPRODUCING IN VITRO THE METABOLIC IDIOSYNCRASY OF HUMANS
#702RAPID SCREEN FOR REPRODUCTIVE TOXICANTS
#703Force-induced magnetization contrast for diagnosis and imaging
#704Label-free Cellular Pharmacology For Drug Antitarget Assessment
#705VENTRICULAR INDUCED PLURIPOTENT STEM (ViPS) CELLS FOR GENERATION OF AUTOLOGOUS VENTRICULAR CARDIOMYOCYTES AND USES THEREOF
#706YEAST ECTOPICALLY EXPRESSING ABNORMALLY PROCESSED PROTEINS AND USES THEREFOR
#707MICROPATTERNED CO-CULTURE SYSTEMS AS INFECTIOUS DISEASE ANALYSIS PLATFORMS
#708Method for determination and quantification of radiation or genotoxin exposure
#709Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics
#710COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE
#711Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system
#712High throughput assays for transmissible spongiform encephalopathies (TSE)
#713Determining liver toxicity of an agent using metabolite biomarkers
#714Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments
#715Methods and kits for ascertaining biosafety of an agent
#716ASSAYS TO PREDICT CARDIOTOXICITY
#717Device for examining myocardial toxicity, chip for examining myocardial toxicity and method for examining myocardial toxicity
#718Methods of Quantifying Methotrexate Metabolites
#719Liver engrafting cells, assays, and uses thereof
#720METHODS FOR DETERMINING EFFICACY OF A THERAPEUTIC REGIMEN AGAINST DELETERIOUS EFFECTS OF CYTOTOXIC AGENTS IN HUMAN
#721Use of Induced Pluripotent Cells and other Cells for Screening Compound Libraries
#722METHODS OF SCREENING AGENTS FOR ACTIVITY USING TELEOSTS
#723Probe reagent for measuring oxidative stress
#724Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
#725T-cell death-inducing epitopes
#726Method for assessing embryotoxicity
#727METHODS AND COMPOSITIONS FOR IDENTIFYING, PRODUCING AND USING PLANT-DERIVED PRODUCTS FOR MODULATING CELL FUNCTION AND AGING
#728Humanized FcγR mice
#729PROTEIN BIOMARKERS FOR IN VITRO TESTING OF DEVELOPMENTAL TOXICITY AND ENBRYOTOXICITY OF CHEMICAL SUBSTANCES
#730Selection of stem cell clones with defined differentiation capabilities
#731Method of Toxicological Assessment
#732Method for enhancing transport of semiconductor nanocrystals across biological membranes
#733Methods of Treating Neurological Autoimmune Disorders with Cyclophosphamide
#734SCREENING FOR NON-GENOTOXIC CARCINOGENS
#735METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS
#736Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
#737WELL-BASED FLOW SYSTEM FOR CELL CULTURE
#738PHASE II DETOXIFICATION AND ANTIOXIDANT ACTIVITY
#739METHOD FOR DISCOVERING DRUGS
#740Metabolic Biomarkers Of Drug-Induced Cardiotoxicity
#741NOVEL TREATMENT OF HEART DISEASES
#742CARDIOVASCULAR SAFETY ASSAY
#743Hepatotoxicity Molecular Models
#744Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein
#745Assays for mutagenesis detection
#746Methods for diagnosis of and methods and vectors for recombinant toxin expression
#747Drug Screening Using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#748System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells
#749BIOASSAY FOR YOKUKANSAN
#750TDP-43-storing cell model
#751Method of bioassaying yokukansan
#752CENTROSOME AMPLIFICATION AS A BIOSENSOR FOR DNA DAMAGE
#753TOXICITY SCREENING METHODS
#754Method for Predicting Respiratory Toxicity of Compounds
#755Methods for determining efficacy of chemotherapeutic agents
#756MESP1 AS A MASTER REGULATOR OF MULTIPOTENT CARDIOVASCULAR PROGENITOR SPECIFICATION AND USES THEREOF
#757Cell-based antioxidant protection assay
#758Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
#759Genotoxicity as a biomarker for inflammation
#760Stable cell lines expressing hERG
#761DNA FRAGMENTATION ASSAY
#762Cells useful for immuno-based Botulinum toxin serotype A activity assays
#763Human blood brain barrier model
#764Immuno-based retargeted endopeptidase activity assays
#765Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#766Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds
#767Methods for the delivery of toxins or enzymatically active portions thereof
#768Methods for identifying inhibitors of botulinum neurotoxins
#769Drug screening using islet cells and islet cell progenitors from human embryonic stem cells
#770METHODS FOR DIAGNOSING BIOLOGICAL SAMPLES CONTAINING STEM CELLS
#771METHODS OF QUANTIFYING METHOTREXATE METABOLITES
#772COMPOUNDS
#773Use of β-2-microglobulin to assess glomerular alterations and damage in the kidney
#774COMBINED SCALABLE IN VITRO DIFFERENTIATION SYSTEM FOR HUMAN BLASTOCYST-DERIVED STEM (HBS) CELLS OR CELLS DERIVED FROM HBS CELLS FOR DIRECT ASSAY APPLICATION IN MULTIWELL PLATES
#775Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
#776Liver cell toxicity assay
#777Method for analyzing the effect of a gaseous medium on a biological test system using an extracellular metabolization system
#778Assaying cellular markers for the evaluation of tumors
#779PROCEDURE FOR LONG TERM CORNEAL CULTURE
#780Method of preventing fat graft resorption by administering fat-derived cells and poloxamer P 188
#781Non-dividing cell-based assay for high throughput antiviral compound screening
#782Metabolically Competent Cell Lines
#783Toxicity assay based on human blastocyst-derived stem cells and progenitor cells
#784Method and Kit for Testing Stress Effects in Living Organisms
#785HIGH THROUGHPUT METHODS FOR CHARACTERIZATION OF ANTIBODIES
#786Pulsing of Bile Compartments in Sandwich-Cultured Hepatocytes
#787Chimeric Fcγ receptor and method for determination of ADCC activity by using the receptor
#788Engineered Lung Tissue Construction for High Throughput Toxicity Screening and Drug Discovery
#789METHODS FOR MODELING INFECTIOUS DISEASE AND CHEMOSENSITIVITY IN CULTURED CELLS AND TISSUES
#790RECEPTOR FOR AMYLOID BETA AND USES THEREOF
#791High throughput assays for transmissible spongiform encephalopathies (TSE)
#792Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
#793Modified Metallothioneins and Methods for Screening and Treatment of Diseases Associated With Oxidative Stress
#794Quantitative analysis of in vivo mutation at the locus
#795Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
#796Multinetwork nerve cell assay platform with parallel recording capability
#797Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein
#798Toxicology and Cellular Effect of Manufactured Nanomaterials
#799Botulinum toxin screening assays
#800Methods for Identifying Functionally Related Genes and Drug Targets
#801Inhibitor of Anti-Apoptotic Proteins
#802Sperm-specific cation channel, CatSper4, and uses therefor
#803Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior
#804Method for screening agent with angiogenic-modulating activities using teleost embryo
#805Method of in vivo screening for cardiac toxic agents using teleost
#806Single-cell biosensor for the measurement of GPCR ligands in a test sample
#807THREE-DIMENSIONAL CELLULAR ARRAY CHIP AND PLATFORM FOR TOXICOLOGY ASSAYS
#808Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
#809In vitro Assay Methods for Classifying Embryotoxicity of Compounds
#810COMPOSITIONS AND METHODS FOR DETERMINING NEPHROTOXICITY
#811MOLECULAR TOXICOLOGY MODELING
#812METHODS FOR SCREENING FOR AGENTS THAT AFFECT DEVELOPMENT
#813PRO1120 polypeptides
#814Cytotoxicity mediation of cells evidencing surface expression of CD44
#815PRIMARY RAT HEPATOCYTE TOXICITY MODELING
#816Method for determination and quantification of radiation or genotoxin exposure
#817PREDICTION OF GENOTOXICITY
#818Library From Toxin Mutants, And Methods Of Using Same
#819ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY ASSAY
#820UNIVERSAL FLUORESCENT SENSORS
#821SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#822Methods of measuring cell viability in tissue engineered products
#823Method for Testing Substances or Mixtures of Substances,Use of Said Method and Corresponding Test Kits
#824Modulators of alpha-synuclein toxicity
#825LABORATORY-SELECTED COLONIES OF WESTERN CORN ROOTWORM WITH INCREASED TOLERANCE TO MAIZE CONTAINING EVENT DAS-59122-7 AND METHODS OF USE
#826Laboratory-selected colonies of western corn rootworm with increased tolerance to maize containing event DAS-59122-7
#827Islet Cells from Human Embryonic Stem Cells
#828Methods for generating and screening fusion protein libraries and uses thereof
#829Single-cell biosensor for the measurement of GPCR ligands in a test sample
#830Cells and methods for estimation of effects on neurological dysfunction
#831Method for selecting therapeutic agents for cancer treatment
#832Methods for determining efficacy of chemotherapeutic agents
#833Cell culture well-plates having inverted colloidal crystal scaffolds
#834Method for screening toxin neutralizing peptide, STX2 inhibiting peptide and verotoxin neutralizing agent
#835Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease
#836METHOD FOR EXTRACTING QUANTITATIVE INFORMATION RELATING TO AN INFLUENCE ON A CELLULAR RESPONSE
#837Stabilized bioactive peptides and methods of identification, synthesis, and use
#838Accessing the toxic potential of nanomaterials
#839methods for testing toxicity of substances using donated human organs or tissues
#840MICROCYTOXICITY ASSAY BY PRE-LABELING TARGET CELLS
#841METHOD OF DEVELOPING A PHARMACOKINETIC PROFILE OF A XENOBIOTIC DISPOSITION IN A MAMMALIAN TISSUE
#842Bone Marrow Proliferation Assay
#843Biomarkers of metabolic responses to hepatic drugs
#844Cardiovascular safety assay
#845ASSESSMENT AND MITIGATION OF OXIDATIVE STRESS IN SKIN
#846Monitoring Z-values for clinical data interpretation
#847The Redox/Fyn/c-Cbl Pathway
#848Lipophilic dye-based fret assays for clostridal toxin activity
#849Methods of screening agents for activity using teleosts
#850Islet Cells from Human Embryonic Stem Cells
#851METHOD FOR DETERMINING GENOTOXICITY
#852Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology
#853Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
#854Non-invasive, in vitro functional tissue assay systems
#855Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1
#856Method for Screening for Compounds Safe for Gastric Mucosa
#857Evaluation of the Toxicity of Pharmaceutical Agents
#858Methods for determining efficacy of chemotherapeutic agents for a patient prior to treatment
#859Novel protein kinase molecules and uses therefor
#860SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#861Compositions and methods for treatment of protein misfolding diseases
#862Method for Obtaining a Singular Cell Model Capable of Reproducing in Vitro the Metabolic Idiosyncrasy of Humans
#863Imaging of enzyme activity
#864Antibodies against the PRO1754 polypeptides
#865METHODS OF SCREENING AGENTS FOR CYTOTOXIC AND ANTIMICROBIAL ACTIVITY
#866NEUROTOXICITY METHODS PROCESS
#867Extended Primary Retinal Cell Culture and Stress Models, and Methods of Use
#868Methods and Compositions for Modulating a Steroid Receptor
#869Microcystins as agents for treatment of cancer
#870Pharmacologic Method Of Lowering Cholesterol Production
#871SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME
#872Methods for Determining the Potency, Specificity, and Toxicity of Hematopoietic Prostaglandin D2 Synthase
#873Normalizing cell assay data for models
#874Cellular predictive models for toxicities
#875Kinetic metabolic assay for antifungal susceptibility testing
#876Antibodies to the PRO1561 polypeptide
#877Methods for comparing the immunogenicity of products and uses thereof
#878Toxicity screening methods
#879NUCLEI DENSITY AND NUCLEI AREA METHODS FOR DETERMINING THE EFFECTS OF A BOTULINUM TOXIN ON MUSCLES
#880Excretable Reporter Systems
#881Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#882Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
#883Methods for Detecting DNA Damage and Screening for Cancer Therapeutics
#884Multiparameter FACS assays to detect alterations in cellular parameters and to screen small molecule libraries
#885Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
#886Miniaturized cell array methods and apparatus for cell-based screening
#887Radiolabeled astemizole and method of making
#888CELLS HAVING A SPECTRAL SIGNATURE AND METHODS OF PREPARATIONS AND USE THEREOF
#889Methods of screening agents for activity using teleosts
#890Stable cell lines expressing hERG
#891Epothilone resistant cell lines
#892Cell adhesion and extracellular matrix proteins
#893Molecular nephrotoxicology modeling
#894Toxicity typing using liver stem cells
#895Method and apparatus for signal transduction pathway profiling
#896Molecular nephrotoxicology modeling
#897In vitro erythroid micronucleus assay for genotoxicity
#898Method to detect antigen-specific cytolytic activity
#899Screening of compounds for GAT2 transporter activity
#900Method for the in vitro titration of an NCTA application thereof in a method for the evaluation and/or monitoring of a biological product production method